Abstract:The mechanism by which nitroglycerin (or glyceryl trinitrate, GTN) exerts its biologic effects has remained a mystery for decades. In recent years it has been reported that aldehyde dehydrogenase 2 (ALDH-2) is the only enzyme responsible for the bioactivation of GTN at therapeutically relevant concentrations. Furthermore, observations in animal models suggest that ALDH-2 mediated denitrification of GTN generates a free radical intermediate which inactivates ALDH-2 leading to nitrate tolerance. However, the impact of ALDH-2 on the development of GTN tolerance has not been investigated in humans. We studied healthy volunteers who were heterozygous (n=12) or homozygous (n=11) for the ALDH-2 Glu504Lys polymorphism, a mutation that markedly reduces ALDH-2 activity, as well as a group without the polymorphism (n=12). We examined the systemic hemodynamic responses to the acute administration of transdermal GTN (0.6 mg/hour) and following seven days of continuous transdermal GTN treatment. We also examined arterial forearm blood flow (FBF) responses to brachial artery infusions of GTN, acetylcholine as well as L-NMMA before and after seven days of continuous transdermal GTN therapy. The acute blood pressure responses to transdermal GTN were similar in all three groups. This initial hypotensive response was lost after sustained GTN therapy in all three groups, indicating the development of tolerance. Prior to sustained GTN treatment, the FBF response to intra-arterial GTN was significantly smaller in subjects with the ALDH-2 polymorphism as compared to those without, although the FBF response to acetylcholine was similar in the three genotype groups. Following seven days of sustained transdermal GTN therapy, the FBF responses to both intra-arterial GTN and acetylcholine were blunted in all 3 groups, indicating the development of both tolerance and endothelial dysfunction. Prior to GTN therapy, the FBF response to L-NMMA was similar in the three genotype groups. Following sustained transdermal GTN therapy, the response to L-NMMA was significantly reduced in the group without the polymorphism while, interestingly, the responses to L-NMMA in the polymorphism group remained unchanged. Our results demonstrate that ALDH-2 is not responsible for the acute, systemic hemodynamic responses to GTN nor is it responsible for the development of tolerance or endothelial dysfunction during sustained GTN exposure.

Progresses in nitrate biotransformation and tolerance mechanisms

Progress in Research in Role of Mitochondrial Aldehyde Dehydrogenase in Nitrate Tolerance

The effect of peroxynitrite decomposition catalyst MnTBAP on aldehyde dehydrogenase-2 nitration by organic nitrates: role in nitrate tolerance

Targeting nitrosative stress for neurovascular protection: new implications in brain diseases.

Explaining the phenomenon of nitrate tolerance

Identification of the Enzymatic Mechanism of Nitroglycerin Bioactivation.

Progress in tolerance of nitrate

Targeting Nitrosative Stress as a Therapeutic Strategy for Neurovascular Protection in Brain Ischemia

Nitrite Modulates Aminoglycoside Tolerance by Inhibiting Cytochrome Heme-Copper Oxidase in Bacteria

Preventive Effect of Tetramethylpyrazine on Nitroglycerin-Tolerance in Rats by Improving Oxidative Stress and Ribosome Homeostasis

[Oxidative Stress in Nitroglycerin Tolerance and Treatment with 3,4,5,6-Tetrahydroxyxanthone].

Aldehyde Dehydrogenase 2 Protects Human Umbilical Vein Endothelial Cells Against Oxidative Damage and Increases Endothelial Nitric Oxide Production to Reverse Nitroglycerin Tolerance.

Progress in sodium nitrite based therapies for ischaemic diseases

Study on the role of HO-1 in the reduction of nitroglycerin tolerance

The interplay between oxidative stress and bioenergetic failure in neuropsychiatric illnesses: can we explain it and can we treat it?

ALDEHYDE DEHYDROGENASE 2: A CRITICAL APPRAISAL OF ITS ROLE AS A MEDIATOR OF THE ACUTE AND SUSTAINED VASCULAR RESPONSES TO NITROGLYCERIN

Research Progress of Nitroglycerin and Mitochondrial Acetaldehyde Dehydrogenase in Myocardial Protection

Preclinical study for the ameliorating effect of l-ascorbic acid for the oxidative stress of chronic administration of organic nitrates on myocardial tissue in high sucrose/fat rat model

Comparing the Role of Glutathione-S-transferase and Mitochondrial Aldehyde Dehydrogenase in Nitroglycerin Biotransformation and the Correlation with Calcitonin Gene-Related Peptide.

Demethylbellidifolin prevents nitroglycerin tolerance via improved aldehyde dehydrogenase 2 activity.

Repurposing Nitazoxanide As a Novel Anti‐atherosclerotic Drug Based on Mitochondrial Uncoupling Mechanisms